MD’s Address

From the desk of Managing Director

Mr. Pranav Gupta,Managing Director

Mr. Pranav Gupta,Managing Director

Our Vision- Creating a responsible enterprise that delivers VALUE

Dear Shareholders,

At the outset, I would thank you for being with us and reposing your confidence on the management. The company has consolidated its position during the last financial year and has set drivers in place for laying a strong foundation for the future. I do believe strongly that the strategic decisions taken by management over the last couple of years will yield positive results in the coming year. The year 2011-12 has been a tough one in the face of the tightened liquidity scenario, high interest rates, the euro zone debt crisis and the depreciation of Indian currency. Despite the fiscal challenges affecting the operating environment, the company has achieved a gross turnover of INR 10123 million for the year 2011-12. This represents a growth of 50% over the last year. Net Profits came in at INR 512 million.

Amongst the operational achievements and developments, at the Derabassi site, your company has successfully commissioned the Multi-Purpose Block that augments the amorphous capacities. In the sterile space, with the commissioning of new sterile block, the company has doubled its capacity to 20 tons per annum for the manufacturing of the sterile range of products. With the expansion the stage is set for the company to build on its accomplishments during the coming year. The current fiscal was also significant as the company diversified horizontally to minimize its dependence on a single segment for growth. From being a standalone antibiotic manufacturer, your company is becoming a differentiated antibiotic and non-antibiotic API manufacturer. The company has activated production for the life style drugs from its new facility in Lalru. The company has been working in over 10 different therapies covering cardiovascular, hypertensive, diabetes, oncology, osteoporosis and central nervous system. The company looks to build revenues and growth on the new range of products that would not only bolster the top-line, but more importantly, concentrate on expanding margins. With infrastructural expansions in place, right set of skills and capabilities in research and chemistry, a diversified basket of products, your company has all the drivers in place for the next level of growth – the growth that drives the value for each of the stakeholders.

Our objective towards creating a responsible enterprise will be led by the following actions:-

 

Taking your company to newer geographies
Achieving highest International quality standards
Growth through developments in research and development
Headway in the Contract manufacturing Space
Horizontal growth through the diversified basket
Vertical integration for value maximization
Business Outlook

Pranav Gupta